Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05673200 |
Title | Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer |
Recruitment | Suspended |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Mayo Clinic Hospital in Arizona | Phoenix | Arizona | 85054 | United States | Details | |
UC Irvine Health Cancer Center-Newport | Costa Mesa | California | 92627 | United States | Details | |
UC Irvine Health/Chao Family Comprehensive Cancer Center | Orange | California | 92868 | United States | Details | |
University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | United States | Details | |
Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States | Details | |
Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States | Details | |
University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
University of Pittsburgh Cancer Institute (UPCI) | Pittsburgh | Pennsylvania | 15232 | United States | Details |